FDA inspection
Aurobindo Pharma Limited: FDA inspection ending Feb 10, 2026
FDA inspection 1304312 · Jedcherla Mandal, Mahabubnagar
Key facts
| Inspection ID | 1304312 |
|---|---|
| Firm | Aurobindo Pharma Limited |
| FEI number | 3007373532 |
| Address | Unit-Vii, Sy No. 411/P, 425/P, 434/P, 435/P & 458/P, Plot S1 Part Sez, Tsiic, Green Industrial Park, Polepally |
| City | Jedcherla Mandal, Mahabubnagar |
| Fiscal year | 2026 |
| Inspection end date | Feb 10, 2026 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data